Pharma Marketletter - Battle commences on generic gabapentin
Following the decision of the US District Court of New Jersey to deny a request by Pfizer, the world’s largest drugmaker, for a temporary restraining order prohibiting Alpharma from selling generic gabapentin, the latter firm announced the launch of its …
Related Results
Other treatment options for menopausal symptoms
Pfizer Japan Obtains Manufacturing Approval of Gabapentin for
Recent approvals spur CNS category. (central nervous system)
Depomed Begins Dosing Patients in Phase 2 Trial For Gabapentin GR to Treat Me…
Post-herpetic neuralgia: a review of advances in treatment and prevention
Want to read the whole article? You can purchase it here. It’s quick and easy.
